Literature DB >> 25445041

Epigenetic upregulation of alpha-synuclein in the rats exposed to methamphetamine.

Wenda Jiang1, Ji Li2, Zhuang Zhang2, Hongxin Wang3, Zhejian Wang4.   

Abstract

Abuse of methamphetamine (METH) increases the risk of occurrence of Parkinson׳s disease (PD) in the individuals. Increased expression of synaptic protein α-synuclein (encoded by gene Snca) is remarkably associated with the neuronal loss and motor dysfunction in the patients with PD. The present study aimed to explore the epigenetic mechanism underlying the altered expression of α-synuclein in substantia nigra in the rats previously exposed to METH. Exposure to METH induced significant behavioral impairments in the rotarod test and open field test, as well as the upregulation of cytokine synthesis in the substantia nigra. Significantly increased expression of α-synuclein was also observed in the substantia nigra in the rats exposed to METH. Further chromatin immunoprecipitation and bisulfite sequencing studies revealed a significantly decreased cytosine methylation in the Snca promoter region in the rats exposed to METH. It was found that the occupancy of methyl CpG binding protein 2 and DNA methyltransferase 1 in Snca promoter region was also significantly decreased in the substantia nigra in the modeled rats. These results advanced our understanding on the mechanism of the increased incidence of PD in the individuals with history use of METH, and shed novel lights on the development of therapeutic approaches for the patients conflicted with this neurological disorder.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA methylation; DNA methyltransferase 1; Methamphetamine; Methyl CpG binding protein 2; α-synuclein

Mesh:

Substances:

Year:  2014        PMID: 25445041     DOI: 10.1016/j.ejphar.2014.10.043

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

Review 1.  Epigenetic regulation in Parkinson's disease.

Authors:  Catherine Labbé; Oswaldo Lorenzo-Betancor; Owen A Ross
Journal:  Acta Neuropathol       Date:  2016-06-29       Impact factor: 17.088

2.  Self-administration of methamphetamine alters gut biomarkers of toxicity.

Authors:  Amanda Flack; Amanda L Persons; Sharanya M Kousik; T Celeste Napier; Anna Moszczynska
Journal:  Eur J Neurosci       Date:  2017-08       Impact factor: 3.386

3.  Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease.

Authors:  Anas Arab; Jana Ruda-Kucerova; Alzbeta Minsterova; Eva Drazanova; Nikoletta Szabó; Zenon Starcuk; Irena Rektorova; Amit Khairnar
Journal:  Neurotox Res       Date:  2019-06-18       Impact factor: 3.911

Review 4.  The Role of α-Synuclein in Methamphetamine-Induced Neurotoxicity.

Authors:  Manqing Wu; Hang Su; Min Zhao
Journal:  Neurotox Res       Date:  2021-02-08       Impact factor: 3.911

Review 5.  Epigenetic Modifications, Alcoholic Brain and Potential Drug Targets.

Authors:  Ashok Jangra; Chandra Shaker Sriram; Suryanarayan Pandey; Priyansha Choubey; Prabha Rajput; Babita Saroha; Babul Kumar Bezbaruah; Mangala Lahkar
Journal:  Ann Neurosci       Date:  2016-10-04

6.  Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes.

Authors:  Shabnam Nohesara; Mohammad Ghadirivasfi; Mahmood Barati; Mohammad-Reza Ghasemzadeh; Samira Narimani; Zohreh Mousavi-Behbahani; Mohammadtaghi Joghataei; Mansoureh Soleimani; Mozhgan Taban; Soraya Mehrabi; Sam Thiagalingam; Hamid Mostafavi Abdolmaleky
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-10-18       Impact factor: 3.568

7.  Neurotoxic Methamphetamine Doses Increase LINE-1 Expression in the Neurogenic Zones of the Adult Rat Brain.

Authors:  Anna Moszczynska; Amanda Flack; Ping Qiu; Alysson R Muotri; Bryan A Killinger
Journal:  Sci Rep       Date:  2015-10-14       Impact factor: 4.379

8.  BPOZ-2 Gene Delivery Ameliorates Alpha-Synucleinopathy in A53T Transgenic Mouse Model of Parkinson's Disease.

Authors:  Avik Roy; Suresh Babu Rangasamy; Madhuchhanda Kundu; Kalipada Pahan
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

9.  Does Repeated Methamphetamine Exposure at Different Regimens Cause Parkinsonian-Like Behavior in Rats?

Authors:  Neda Valian; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

Review 10.  Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease.

Authors:  Carla Ferreira; Catarina Almeida; Sandra Tenreiro; Alexandre Quintas
Journal:  Life (Basel)       Date:  2020-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.